Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

Related Articles by Review for PubMed (Select 21124887)

1.

Colorectal cancer screening for average-risk North Americans: an economic evaluation.

Heitman SJ, Hilsden RJ, Au F, Dowden S, Manns BJ.

PLoS Med. 2010 Nov 23;7(11):e1000370. doi: 10.1371/journal.pmed.1000370. Erratum in: PLoS Med. 2012 Nov;9(11). doi: 10.1371/annotation/0fd49c83-2c6d-42b5-a8c1-45a0aaedaa77.

2.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

3.

Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer [Internet].

Zauber AG, Lansdorp-Vogelaar I, Wilschut J, Knudsen AB, van Ballegooijen M, Kuntz KM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Dec 20.

4.

A Comparison of the Cost-Effectiveness of Fecal Occult Blood Tests with Different Test Characteristics in the Context of Annual Screening in the Medicare Population [Internet].

van Ballegooijen M, Habbema JDF, Boer R, Zauber AG, Brown ML.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2003 Aug 09.

5.

Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.

Dinh TA, Alperin P, Walter LC, Smith R.

J Gen Intern Med. 2012 Jun;27(6):730-8. doi: 10.1007/s11606-011-1972-6. Epub 2012 Jan 12. Review.

6.

[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].

Quintero E.

Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Review. Spanish.

PMID:
19577340
7.

Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature.

Skally M, Hanly P, Sharp L.

Appl Health Econ Health Policy. 2013 Jun;11(3):181-92. doi: 10.1007/s40258-013-0010-8. Review.

PMID:
23549792
8.

Cost-effectiveness of colonoscopy.

Zauber AG.

Gastrointest Endosc Clin N Am. 2010 Oct;20(4):751-70. doi: 10.1016/j.giec.2010.07.008. Review.

9.

An international review of the main cost-effectiveness drivers of virtual colonography versus conventional colonoscopy for colorectal cancer screening: is the tide changing due to adherence?

Kriza C, Emmert M, Wahlster P, Niederländer C, Kolominsky-Rabas P.

Eur J Radiol. 2013 Nov;82(11):e629-36. doi: 10.1016/j.ejrad.2013.07.019. Epub 2013 Aug 12. Review.

PMID:
23938237
10.

Cost-effectiveness of computed tomography colonography in colorectal cancer screening: a systematic review.

Hanly P, Skally M, Fenlon H, Sharp L.

Int J Technol Assess Health Care. 2012 Oct;28(4):415-23. doi: 10.1017/S0266462312000542. Epub 2012 Sep 24. Review.

PMID:
23006522
11.

Participation in colorectal cancer screening: a review.

Vernon SW.

J Natl Cancer Inst. 1997 Oct 1;89(19):1406-22. Review.

12.

Participation in colorectal cancer screening trials after first-time invitation: a systematic review.

Khalid-de Bakker C, Jonkers D, Smits K, Mesters I, Masclee A, Stockbrügger R.

Endoscopy. 2011 Dec;43(12):1059-86. doi: 10.1055/s-0031-1291430. Epub 2011 Dec 1. Review.

PMID:
22135196
13.

Screening for colorectal cancer with immunochemical faecal occult blood tests.

Faivre J, Dancourt V, Lejeune C.

Dig Liver Dis. 2012 Dec;44(12):967-73. doi: 10.1016/j.dld.2012.07.004. Epub 2012 Aug 13. Review.

PMID:
22898146
14.

FIT testing: an overview.

Day LW, Bhuket T, Allison J.

Curr Gastroenterol Rep. 2013 Nov;15(11):357. doi: 10.1007/s11894-013-0357-x. Review.

PMID:
24218070
15.

Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.

Whitlock EP, Lin JS, Liles E, Beil TL, Fu R.

Ann Intern Med. 2008 Nov 4;149(9):638-58. Epub 2008 Oct 6. Review.

PMID:
18838718
16.

Evidence for colorectal cancer screening.

Bretthauer M.

Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):417-25. doi: 10.1016/j.bpg.2010.06.005. Review.

PMID:
20833346
17.

Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.

Massat NJ, Moss SM, Halloran SP, Duffy SW.

J Med Screen. 2013;20(3):125-48. doi: 10.1177/0969141313501292. Review.

PMID:
24197771
18.

Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Hewitson P, Glasziou P, Irwig L, Towler B, Watson E.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001216. Review.

PMID:
17253456
19.

Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening.

Rabeneck L, Rumble RB, Thompson F, Mills M, Oleschuk C, Whibley A, Messersmith H, Lewis N.

Can J Gastroenterol. 2012 Mar;26(3):131-47. Review.

20.

Colorectal cancer screening--optimizing current strategies and new directions.

Kuipers EJ, Rösch T, Bretthauer M.

Nat Rev Clin Oncol. 2013 Mar;10(3):130-42. doi: 10.1038/nrclinonc.2013.12. Epub 2013 Feb 5. Review.

PMID:
23381005
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk